scanify attracts new investors and expands its management team.
Scanify GmbH, one of the innovation leaders in the development of anti-counterfeiting technologies, is expanding its investor base and gaining renowned managers for further company growth. The managers and entrepreneurs Metin Duman and Prof. Dr. Jan Luccarda have joined the company based in Holzwickede near Dortmund as new shareholders and managing directors. The investment capital in the 7-digit range is to flow into the further development of the technology as well as into the further expansion of the company.
„With Metin Duman and Prof. Dr. Jan Luccarda, we now have two strong growth partners at our side who share the same entrepreneurial values and who, like us, have a strong innovation and entrepreneurial DNA,“ says
scanify founder and CEO Cüneyt Göktekin.
„Metin Duman, as managing partner of numerous technology-related companies, has over 25 years of management experience and exceptional entrepreneurship. His strategic foresight combined with his operational excellence and experience in building organic corporate structures will be a crucial building block for our long-term success. With Prof. Dr. Jan Luccarda, our investor and management team is strengthened by decades of experience from the packaging industry. In particular, his expertise in the topics of traceability and anti-counterfeiting will strengthen our market position in the long term. I am convinced that the profound know-how and additional capital will once again accelerate our further entrepreneurial development and scanify will benefit from the additional wealth of experience.“
Metin Duman is enthusiastic about his commitment: „I am pleased to be able to actively support scanify‘s growth through targeted support of both strategic and operational measures and by providing investment capital. Brand manufacturers in particular need innovative solutions for counterfeit protection in today‘s world. scanify will become an important partner for them with innovative technologies and solutions.“
Prof. Dr. Jan Luccarda sees enormous potential in the healthcare market in particular. „Especially in the current pandemic, scanify PrintID with printable and invisible security features as a track & trace solution can offer counterfeit protection in the short term. Not only original packaging, but also ID documents in particular, such as vaccination cards, can thus be efficiently distinguished from counterfeits with scanify PrintID technology.“
About Scanify GmbH:
Scanify GmbH, based in Holzwickede near Dortmund, Germany, develops and distributes innovative technologies and solutions for the protection of products and packaging against counterfeiting. The company‘s research and development expertise focuses on smartphone-based image processing, pattern recognition using artificial intelligence and the application of innovative printing technologies to protect intellectual property. The customer portfolio includes companies from a wide range of industries, and the technology, which is equipped with a large number of its own patents, addresses the automotive, pharmaceutical and healthcare sectors in particular. More information at www.scanify.de
Cüneyt Göktekin (Managing Director)
59439 Holzwickede, Germany
Phone: +49 2301 91 889 – 240